RJA
BHVN icon

Raymond James & Associates’s Biohaven BHVN Stock Holding History

Raymond James & Associates’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$396K Sell
7,919
-97
-1% -$3.77K ﹤0.01% 3243
2024
Q2 		$278K Sell
8,016
-329
-4% -$13K ﹤0.01% 3418
2024
Q1 		$456K Sell
8,345
-20,154
-71% -$998K ﹤0.01% 3107
2023
Q4 		$1.22M Buy
28,499
+954
+3% +$29.7K ﹤0.01% 2402
2023
Q3 		$716K Buy
27,545
+14,065
+104% +$292K ﹤0.01% 2667
2023
Q2 		$322K Buy
+13,480
New +$232K ﹤0.01% 3211

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Raymond James & Associates's BHVN Position: Q3 2024 in Review

Raymond James & Associates reduced its Biohaven (BHVN) stake by 1.2% in Q3 2024, selling an estimated $3.77K and leaving 7,919 shares worth $396K. The position accounts for ﹤0.01% of the portfolio, ranked #3243.

Raymond James & Associates first reported a position in BHVN in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.22M in Q4 2023. 254 funds tracked by Wall St. Rank hold BHVN as of Q3 2024.

  • Raymond James & Associates held 7,919 shares of Biohaven worth $396K as of Q3 2024.
  • Raymond James & Associates sold 97 Biohaven shares in Q3 2024, an estimated $3.77K.
  • Biohaven made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3243 holding.
  • Raymond James & Associates first reported a position in Biohaven in Q2 2023 and has held it in 6 quarters since.
  • Raymond James & Associates's Biohaven position peaked at $1.22M in Q4 2023.
  • 254 funds tracked by Wall St. Rank held Biohaven as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.